Risks and benefits of phase 1 oncology trials, revisited
- PMID: 15745986
- DOI: 10.1056/NEJMe058007
Risks and benefits of phase 1 oncology trials, revisited
Comment in
-
Phase 1 clinical trials in oncology.N Engl J Med. 2005 Jun 9;352(23):2451-3; author reply 2451-3. doi: 10.1056/NEJM200506093522319. N Engl J Med. 2005. PMID: 15944433 No abstract available.
-
Phase 1 clinical trials in oncology.N Engl J Med. 2005 Jun 9;352(23):2451-3; author reply 2451-3. N Engl J Med. 2005. PMID: 15948270 No abstract available.
-
Phase 1 clinical trials in oncology.N Engl J Med. 2005 Jun 9;352(23):2451-3; author reply 2451-3. N Engl J Med. 2005. PMID: 15948271 No abstract available.
Comment on
-
Risks and benefits of phase 1 oncology trials, 1991 through 2002.N Engl J Med. 2005 Mar 3;352(9):895-904. doi: 10.1056/NEJMsa042220. N Engl J Med. 2005. PMID: 15745980
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources